CD4 and COVID-19: Evidence now suggests that immune dysregulation in PWH with lower CD4 counts could potentially result in an exaggerated immune response and increased risk of severe COVID-19 by reducing the overall SARS-CoV-2 specific CD4 T cells [10, 35].